172 related articles for article (PubMed ID: 8496977)
21. Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
Richtig E; Soyer HP; Posch M; Mossbacher U; Bauer P; Teban L; Svolba G; Wolf IH; Fritsch P; Zelger B; Volc-Platzer B; Gebhart W; Mischer P; Steiner A; Pachinger W; Hintner H; Gschnait F; Rappersberger K; Pilarski P; Pehamberger H;
J Clin Oncol; 2005 Dec; 23(34):8655-63. PubMed ID: 16260701
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenetics and other molecular targets in the management of pancreatic adenocarcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Merika E; Syrigos KN; Saif MW
JOP; 2010 Jul; 11(4):328-30. PubMed ID: 20601804
[TBL] [Abstract][Full Text] [Related]
23. [Meeting of the American Society of Clinical Oncology (ASCO), San Francisco, May 12-15, 2001].
Azagury M
Rev Med Interne; 2001 Nov; 22(11):1021-5. PubMed ID: 11817112
[No Abstract] [Full Text] [Related]
24. ASCO core values: essential to progress in innovative, quality cancer care.
Horning SJ
J Clin Oncol; 2006 Dec; 24(36):5629. PubMed ID: 17179100
[No Abstract] [Full Text] [Related]
25. 2016 ASCO Annual Meeting.
Lokody I
Lancet Oncol; 2016 Jul; 17(7):875-876. PubMed ID: 27290908
[No Abstract] [Full Text] [Related]
26. Into the future.
Cassileth BR
J Soc Integr Oncol; 2007; 5(4):131. PubMed ID: 19087754
[No Abstract] [Full Text] [Related]
27. Perspectives from the American Society of Clinical Oncology 2014 Conference: breast cancer highlights.
Crozier JA; Perez EA
Future Oncol; 2014 Oct; 10(12):1897-9. PubMed ID: 25386807
[No Abstract] [Full Text] [Related]
28. Society meetings.
Hillman BJ
J Am Coll Radiol; 2012 Mar; 9(3):156. PubMed ID: 22386157
[No Abstract] [Full Text] [Related]
29. The American Society of Clinical Oncology: change, growth, and rebirth.
Young RC
J Clin Oncol; 1990 Oct; 8(10):1757-66. PubMed ID: 2120393
[No Abstract] [Full Text] [Related]
30. From the meeting: Orlando plays host to the 2017 ASCO Genitourinary Cancer symposium.
Fenner A
Nat Rev Urol; 2017 Apr; 14(4):199. PubMed ID: 28290458
[No Abstract] [Full Text] [Related]
31. Larry Norton--president-elect of ASCO. American Society of Clinical Oncology. Interviewed by Ezzie Hutchinson.
Norton L
Lancet Oncol; 2000 Nov; 1():189-92. PubMed ID: 11905658
[No Abstract] [Full Text] [Related]
32. Everything has its price.
Lancet Oncol; 2002 Dec; 3(12):707. PubMed ID: 12473492
[No Abstract] [Full Text] [Related]
33. [Mammary cancerology and gynecology. 35th Congress of the American Society of Clinical Oncology (ASCO) Atlanta (United States), May 1999].
Mabro M
Rev Med Interne; 1999 Oct; 20(10):855-7. PubMed ID: 10573720
[No Abstract] [Full Text] [Related]
34. ASCO 2001 Presidential address.
Einhorn LH
J Clin Oncol; 2001 Sep; 19(18 Suppl):1S-5S. PubMed ID: 11560963
[No Abstract] [Full Text] [Related]
35. Proposing and Meeting the Need for Interdisciplinary Cardio-oncology Subspecialty Training.
Brown SA; Sandhu N
J Card Fail; 2016 Nov; 22(11):934-935. PubMed ID: 27150494
[No Abstract] [Full Text] [Related]
36. Advances highlighted at US cancer meeting.
McCarthy M
Lancet; 2002 May; 359(9320):1835. PubMed ID: 12044383
[No Abstract] [Full Text] [Related]
37. 2020 ASCO Virtual Annual Meeting.
Collingridge D
Lancet Oncol; 2020 Jul; 21(7):885-886. PubMed ID: 32511985
[No Abstract] [Full Text] [Related]
38. Are there too many surgical societies and annual meetings?
Hom L; Organ CH; Twomey PL
Bull Am Coll Surg; 1991 Aug; 76(8):23-6. PubMed ID: 10112208
[No Abstract] [Full Text] [Related]
39. Professional meetings: what's missing?
Gunderman RB
J Am Coll Radiol; 2014 Jul; 11(7):733-4. PubMed ID: 24684900
[No Abstract] [Full Text] [Related]
40. ASCO 2012: a good year for HER2 therapy.
Sledge GW
Clin Breast Cancer; 2012 Aug; 12(4):231. PubMed ID: 22858362
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
